EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CA9‐Targeted PET Imaging for Noninvasive Discrimination of Clear Cell Renal Cell Carcinoma and Associated Tumor Biological Features

Kailei Chen, Sixuan Cheng, Jian Shi iD, Ruijie Liu, Yilong Wu, Xin Zheng, Xinlun Song, Yunxuan Zhang, Lei Liu, Zhihao Wei, Qi Wang, Xinwei Li und 8 weitere

Advanced Science · 2026

DOI: 10.1002/advs.76622 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Kailei Chen und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Positron-Emission Tomography, Antigens, Neoplasm. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shenzhen Medical Research Funds, Natural Science Foundation of Wuhan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Clear cell renal cell carcinoma (ccRCC) is biologically distinct from non‐clear cell renal cell carcinoma (nccRCC), and shows marked intratumoral heterogeneity, yet current imaging modalities lack the ability to noninvasively distinguish histologic subtypes or capture tumor biological features in vivo. Experimental Design An integrative analysis combines CA9‐targeted positron emission tomography (PET) imaging with multi‐omic analyses, histopathological validation, and functional assessment using patient‐derived xenograft (PDX) models. Clinical CA9‐targeted PET imaging is evaluated in patients with renal masses and examined alongside 18 F‐FDG PET.

Results

CA9 is preferentially enriched in ccRCC tumor cells with low background expression in normal kidney tissue. CA9‐targeted PET imaging shows potential for noninvasive discrimination of ccRCC from nccRCC, including lesions with distinct histologies within individual patients. High CA9‐targeted PET uptake is associated with PBRM1 loss‐of‐function alterations, immune pathway suppression with reduced B cell infiltration, metabolic alterations, and enhanced angiogenic activity. Single‐cell and spatial analyses support endothelial enrichment and angiogenesis‐associated programs in CA9‐high regions. CA9‐high PDX models showed greater tumor growth inhibition under axitinib treatment.

Conclusions

CA9‐targeted PET provides proof‐of‐concept evidence for noninvasive discrimination of ccRCC and associated angiogenic and tumor biological features, warranting prospective validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsPositron-Emission TomographyAntigens, NeoplasmCarbonic Anhydrase IXHumansAnimalsMiceFemaleMale

Stichwörter der Autor:innen

PET imagingangiogenesiscarbonic anhydrase 9clear cell renal cell carcinomatumor functional states

Substanzen

Antigens, NeoplasmCarbonic Anhydrase IXCA9 protein, human

Autor:innen und Institutionen

  • Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Institute of Urology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Hubei Province Key Laboratory of Precision Radiation Oncology, Wuhan, China.
  • Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Hubei Key Laboratory of Molecular Imaging, Wuhan, China.
  • Key Laboratory of Biological Targeted Therapy, Ministry of Education, Wuhan, Hubei, China.

ORCID-Profile: Jian Shi, Chunxia Qin, Keshan Wang, Xiaoping Zhang

Förderung

  • National Natural Science Foundation of China
  • Shenzhen Medical Research Funds
  • Natural Science Foundation of Wuhan
  • Shenzhen Science and Technology Program
  • Open Research Fund of Hubei Province Key Laboratory of Precision Radiation Oncology
  • Hubei Science and Technology Innovation Talent Program
  • Wuhan Union Hospital Clinical Translation Program
  • Shenzhen Science and Technology Innovation Program

Zitieren

APA

Chen, K., Cheng, S., Shi, J., Liu, R., Wu, Y., Zheng, X., Song, X., Zhang, Y., Liu, L., Wei, Z., Wang, Q., Li, X., Dong, Z., Liu, Y., Yang, H., Lan, X., Qin, C., Jiang, D., Wang, K., & Zhang, X. (2026). CA9‐Targeted PET Imaging for Noninvasive Discrimination of Clear Cell Renal Cell Carcinoma and Associated Tumor Biological Features. Advanced Science. https://doi.org/10.1002/advs.76622

Vancouver

Chen K, Cheng S, Shi J, Liu R, Wu Y, Zheng X, et al. CA9‐Targeted PET Imaging for Noninvasive Discrimination of Clear Cell Renal Cell Carcinoma and Associated Tumor Biological Features. Advanced Science. 2026. doi:10.1002/advs.76622

BibTeX
@article{Chen2026,
  author = {Chen, Kailei and Cheng, Sixuan and Shi, Jian and Liu, Ruijie and Wu, Yilong and Zheng, Xin and Song, Xinlun and Zhang, Yunxuan and Liu, Lei and Wei, Zhihao and Wang, Qi and Li, Xinwei and Dong, Zirui and Liu, Yuenan and Yang, Hongmei and Lan, Xiaoli and Qin, Chunxia and Jiang, Dawei and Wang, Keshan and Zhang, Xiaoping},
  title = {CA9‐Targeted PET Imaging for Noninvasive Discrimination of Clear Cell Renal Cell Carcinoma and Associated Tumor Biological Features},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.76622}
}
Kostenlos starten →